Cigna Group (CI)
(Delayed Data from NYSE)
$342.32 USD
+5.62 (1.67%)
Updated Aug 16, 2024 04:00 PM ET
After-Market: $342.34 +0.02 (0.01%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth D Momentum A VGM
Cigna (CI) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$396.09 | $435.00 | $355.00 | 17.64% |
Price Target
Based on short-term price targets offered by 22 analysts, the average price target for Cigna comes to $396.09. The forecasts range from a low of $355.00 to a high of $435.00. The average price target represents an increase of 17.64% from the last closing price of $336.70.
Analyst Price Targets (22)
Broker Rating
Cigna currently has an average brokerage recommendation (ABR) of 1.41 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 23 brokerage firms. The current ABR compares to an ABR of 1.41 a month ago based on 23 recommendations.
Of the 23 recommendations deriving the current ABR, 17 are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 73.91% and 8.7% of all recommendations. A month ago, Strong Buy made up 73.91%, while Buy represented 8.7%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/CI.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 17 | 17 | 17 | 16 | 15 |
Buy | 2 | 2 | 2 | 2 | 2 |
Hold | 4 | 4 | 4 | 4 | 4 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.41 | 1.41 | 1.41 | 1.43 | 1.45 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/7/2024 | Truist Securities | David S Macdonald | Strong Buy | Strong Buy |
8/2/2024 | Stephens | Scott Fidel | Strong Buy | Strong Buy |
8/2/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/1/2024 | Edward D. Jones & Company | John Boylan | Hold | Hold |
6/26/2024 | Piper Sandler | Jessica E Tassan | Strong Buy | Strong Buy |
6/18/2024 | Mizuho SecuritiesUSA | Ann K Hynes | Strong Buy | Strong Buy |
6/12/2024 | Cantor Fitzgerald & Co | Sarah James | Strong Buy | Strong Buy |
6/5/2024 | Wells Fargo Securities | Stephen Baxter | Hold | Hold |
5/30/2024 | Robert W. Baird & Co. | Michael Ha | Not Available | Strong Buy |
5/10/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
5/6/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
5/3/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
5/2/2024 | SVB Securities | Whit Mayo | Hold | Hold |
5/2/2024 | Raymond James | John W Ransom | Strong Buy | Strong Buy |
4/8/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
3/29/2024 | Goldman Sachs | Nathan Rich | Hold | Hold |
3/8/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
3/8/2024 | UBS | Kevin Caliendo | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.41 |
ABR (Last week) | 1.41 |
# of Recs in ABR | 23 |
Average Target Price | $396.09 |
LT Growth Rate | 11.50% |
Industry | Medical - HMOs |
Industry Rank by ABR | 215 of 253 |
Current Quarter EPS Est: | 7.34 |